Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
NCT06894225
·
clinicaltrials.gov ↗
PHASE2
Phase
SUSPENDED
Status
12
Enrollment
OTHER
Sponsor class
Stopped
Study team is finding new fundings for the study
Conditions
Recurrent Glioblastoma
Interventions
DRUG:
ACT001
Sponsor
National Neuroscience Institute